Focke M - Search Results

1

Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy.

Twaroch TE, Focke M, Civaj V, Weber M, Balic N, Mari A, Ferrara R, Quirce S, Spitzauer S, Swoboda I, Valenta R. Twaroch TE, et al. Among authors: focke m. J Allergy Clin Immunol. 2011 Jul;128(1):178-184.e7. doi: 10.1016/j.jaci.2011.03.011. Epub 2011 Apr 21. J Allergy Clin Immunol. 2011. PMID: 21513971

2

Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens.

Curin M, Reininger R, Swoboda I, Focke M, Valenta R, Spitzauer S. Curin M, et al. Among authors: focke m. Int Arch Allergy Immunol. 2011;154(3):258-63. doi: 10.1159/000321113. Epub 2010 Sep 21. Int Arch Allergy Immunol. 2011. PMID: 20861648

3

A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy.

Swoboda I, Balic N, Klug C, Focke M, Weber M, Spitzauer S, Neubauer A, Quirce S, Douladiris N, Papadopoulos NG, Valenta R. Swoboda I, et al. Among authors: focke m. J Allergy Clin Immunol. 2013 Oct;132(4):979-81.e1. doi: 10.1016/j.jaci.2013.04.027. Epub 2013 Jun 12. J Allergy Clin Immunol. 2013. PMID: 23763969 No abstract available.

4

Heterogeneity of commercial timothy grass pollen extracts.

Focke M, Marth K, Flicker S, Valenta R. Focke M, et al. Clin Exp Allergy. 2008 Aug;38(8):1400-8. doi: 10.1111/j.1365-2222.2008.03031.x. Epub 2008 Jun 28. Clin Exp Allergy. 2008. PMID: 18564332

5

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.

Focke M, Swoboda I, Marth K, Valenta R. Focke M, et al. Clin Exp Allergy. 2010 Mar;40(3):385-97. doi: 10.1111/j.1365-2222.2009.03443.x. Clin Exp Allergy. 2010. PMID: 20210812

6

Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy.

Twaroch TE, Focke M, Fleischmann K, Balic N, Lupinek C, Blatt K, Ferrara R, Mari A, Ebner C, Valent P, Spitzauer S, Swoboda I, Valenta R. Twaroch TE, et al. Among authors: focke m. Clin Exp Allergy. 2012 Jun;42(6):966-75. doi: 10.1111/j.1365-2222.2012.03996.x. Clin Exp Allergy. 2012. PMID: 22909168 Free PMC article.

7

Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice.

Hufnagl K, Winkler B, Focke M, Valenta R, Scheiner O, Renz H, Wiedermann U. Hufnagl K, et al. Among authors: focke m. J Allergy Clin Immunol. 2005 Aug;116(2):370-6. doi: 10.1016/j.jaci.2005.04.002. J Allergy Clin Immunol. 2005. PMID: 16083792

8

Nonallergenic peptides from surface-exposed areas or B-cell epitopes of allergens for specific immunotherapy.

Focke M, Mahler V, Ball T, Kraft D, Valenta R. Focke M, et al. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):398-9. doi: 10.1159/000053769. Int Arch Allergy Immunol. 2001. PMID: 11307027 No abstract available.

9

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

Focke M, Mahler V, Ball T, Sperr WR, Majlesi Y, Valent P, Kraft D, Valenta R. Focke M, et al. FASEB J. 2001 Sep;15(11):2042-4. doi: 10.1096/fj.01-0016fje. Epub 2001 Jul 24. FASEB J. 2001. PMID: 11511525

10

Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.

Focke M, Linhart B, Hartl A, Wiedermann U, Sperr WR, Valent P, Thalhamer J, Kraft D, Valenta R. Focke M, et al. Clin Exp Allergy. 2004 Oct;34(10):1525-33. doi: 10.1111/j.1365-2222.2004.02081.x. Clin Exp Allergy. 2004. PMID: 15479266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters